About IEC

Home | About IEC | Faculty | 正文

XIAOLIN BI

Title: Professor
Email: BIXL@DMU.EDU.CN
Major: Cell Biology

    Education/Working Experience

     

    06/2012---present Professor, “Pandeng Scholar”,

    Dean, Graduate School (--01/2015);

    Associate Dean, College of Basic Medical Sciences and Chair, Department of

    Biological Sciences (01/2015--), Dalian Medical University, China

    01/2008---12/2013 Senior Investigator, “Outstanding Scholar-Hundred Talent Program”,

    Chinese Academy of Sciences. CAS Key Laboratory for Biological Effects of

    Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy

    of Sciences, China

    08/2004---04/2008 Senior fellow, Laboratory of Biochemistry and Molecular  Biology,

    National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

    09/1999---07/2004  Post-doctorate, National Cancer Institute, National Institutes of

    Health,Bethesda, Maryland, USA

    06/1990---08/1993 Assistant engineer, Lanzhou Institute of Biological  Products,

    Lanzhou,China

     

     

    Participation in the Academic Community

     

    American Association for the Advancement of Science (AAAS)

    Genetics Society of America (GSA)

    American Association for Cancer Research (AACR)

    GRANT REVIEW PANELS AND EDITORIAL BOARDS

    Participation in the   2011-present, National Science Foundation of China

    2013, National Science Foundation, Graduate Research Fellowship Program Panel, USA

    2013, American Journal of Current Genetics, Senior Editorial Board Member

    2014, Journal of Biochemistry and Molecular Biology Research, Editorial Board Member

    2015, Precision Medicine, Associate Editor

    2015, International Journal of Nanomedicine, Consulting Editor

     

     

    Publication

    1. Cong, W., Wang, P., Qu, Y., Tang, J., Bai, R., Zhao, Y., Chen, C., Bi, X. * Biomaterials. 2015. 42:78-86.


2. Chen, H., Wang, B., Feng, W., Du, W., Ouyang, H., Chai, Z., Bi, X.*  Nanotoxicology. 2015. 9(3):302-312.

     

    3.Yuan, Q., Han, J., Cong, W., Ge, Y., Ma, D., Dai, Z., Li, Y., Bi, X. * International Journal of Nanomedicine. 2015. 10: 2420--2421. 

     

    4.Yuan, Q., Han, J., Cong, W., Ge, Y., Ma, D., Dai, Z., Li, Y., Bi, X. * International Journal of Nanomedicine. 2014. 9(1): 4829-4846.

     

     5. Fang, G., Zhang, D., Yin, H., Zheng, L., Bi, X.*, Yuan, L.* Journal of  Cell Science.

    2014. 127 :1631-1639.

     

    6. Wang, Y., Wang, Z., Joshi, BH., Puri, R., Stultz, B., Yuan, Q., Bai, Y., Zhou, P., Yuan, Z., Hursh, DA., Bi, X.*  Oncogene. 2013. 32(33):3857-3866.


7.Liu, W., Jiang,  F.,  Bi,  X.*,  Zhang,  Q*.  Human  Molecular  Genetics.   2012.
21(21):4655-4668.


8.Kong, L., Yuan Y., Zhu, H., Li, Y., Guo, Q., Zhao, Y., Wang, Q., Bi, X.*, Gao,X*.
Biomaterials. 2011. 32(27):6515-6522.


9.Wang, P., Bai, Y., Song, B., Wang, Y., Liu, D., Lai, Y., Bi, X.*, Yuan, Z*. PLoS ONE. 2011. 6(9):e24288.


10.Gao, G., Bi, X., Chen, J., Srikanta, D., Rong, YS. Proc. Nat. Acad. Sci. USA.  2009.


106(26): 10728–10733 (Equal contribution).


11.Bi, X., Srikanta, D., Fanti,L., Pimpinelli,S., Badugu,R., Kellum,R., Rong, Y.S. Proc. Nat. Acad. Sci. USA. 2005. 102(42):15167-15172.


12.Bi, X., Jones, T., Abbasi, F., Lee, H., Stultz, B., Hursh, D., Mortin, M. Oncogene. 2005. 24:8229-8239.


13.Bi, X., Gong, M., Srikanta, D., Rong, Y.S. Genetics. 2005. 171:845-847.


14.Gong, M., Bi, X., Rong, Y.S. Drosophila Information Service. 2005. 88: 79-83 (Equal contribution).


15.Bi, X., Wei, S.D., Rong, Y.S.  Current Biology.  2004. 14:1348-1353.


16.Bi, X., Rong, Y.S. Briefing in functional genomics and proteomics. 2003. 2 (2): 142-146.

     

    17.Bi, X., Kajava, A., Demidenko, Z., Jones, T., Mortin, M. Molecular and Cellular Biology. 2003. 23 (3): 1014-1024.

     

     

    Research Projects/Grants

     

    2010-2014 National  Basic  Research  Program

    Nano-technology to improve anti-cancer drug and its

     

     

    Budget (PI)

     

    2912-2914 “Pandeng Scholar”, Department of Education, Liaoning Province,  China,

    ¥1,500,000 Budget (PI)

    2013-2016 National Science Foundation of China, “Tumor suppressor Caliban is

    regulated by miRNAs for DNA damage response”,¥850,000 Budget (PI)

    2015-2017   “Outstanding Scholar-ShiBaiQian Program”, Liaoning Province, China,

    ¥200,000 Budget (PI)

     

     

    Admission Plan/Requirements 

     

     

    1 PH.D. CANDIDATE,

     

    1 POSTGRADUATE